Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death (VARIANT ICD)
Sponsor: CardioVascular Research Foundation, Korea
A PHASE4 clinical study on Angina Pectoris, Variant and Sudden Cardiac Death, this trial is actively recruiting participants. The trial is conducted by CardioVascular Research Foundation, Korea and has accumulated 15 data snapshots since 2016. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE4
-
Jul 2025 — Sep 2025 [monthly]
Recruiting PHASE4
-
Sep 2024 — Jul 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Mar 2024 — Jul 2024 [monthly]
Recruiting PHASE4
▶ Show 10 earlier versions
-
Jul 2023 — Mar 2024 [monthly]
Recruiting PHASE4
-
Jan 2022 — Jul 2023 [monthly]
Recruiting PHASE4
-
Jan 2021 — Jan 2022 [monthly]
Recruiting PHASE4
-
Jul 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Jan 2019 — Jul 2020 [monthly]
Recruiting PHASE4
-
Nov 2018 — Jan 2019 [monthly]
Recruiting PHASE4
-
Jul 2018 — Nov 2018 [monthly]
Recruiting PHASE4
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE4
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CardioVascular Research Foundation, Korea
- Kee-joon Choi
For direct contact, visit the study record on ClinicalTrials.gov .